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Neurofibromatosis is caused by the loss of neurofibromin (Nf1), leading to peripheral nervous system (PNS)
tumors, including neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs). A long-standing
question has been whether these tumors arise from neural crest stem cells (NCSCs) or differentiated glia.
Germline or conditional Nf1 deficiency caused a transient increase in NCSC frequency and self-renewal in
most regions of the fetal PNS. However, Nf1-deficient NCSCs did not persist postnatally in regions of the
PNS that developed tumors and could not form tumors upon transplantation into adult nerves. Adult P0a-
Cre+Nf1fl/mice developed neurofibromas, andNf1+/Ink4a/Arf/ andNf1/p53+/mice developedMPNSTs,
but NCSCs did not persist postnatally in affected locations in these mice. Tumors appeared to arise from
differentiated glia, not NCSCs.INTRODUCTION
Neurofibromatosis type 1 is among the most prevalent disorders
of the nervous system and is characterized by the formation of
tumors throughout the PNS. It is an autosomal dominant disor-
der caused by mutations in the neurofibromin (Nf1) tumor
suppressor, which encodes a GTPase activating protein that
negatively regulates Ras signaling (Rubin and Gutmann, 2005).
Patients typically inherit one Nf1 mutant allele in the germline,
and somatic mutations inactivate the other allele in cells that
go on to form tumors. Tumors include discrete dermal neurofi-
bromas that are associated with individual nerves as well as
larger plexiform neurofibromas that arise from dorsal root gan-
glia (DRGs), spinal nerve roots, or nerve plexuses (Riccardi,
1999). In addition to these benign tumors, neurofibromatosis
patients can also develop MPNSTs, which often bear additionalmutations in p53 and/or Ink4a/Arf (Agesen et al., 2005; Menon
et al., 1990; Perrone et al., 2003). Neurofibromas and MPNSTs
contain a mixture of normal and neoplastic cells including hyper-
proliferative Schwann cells as well as fibroblasts and other nerve
components in addition to inflammatory cells.
A long-standing question relates to the cell of origin for neuro-
fibromas andMPNSTs. Schwann cells are themost prevalent cell
type in these tumors and have bialleleicNf1mutations (Rubin and
Gutmann, 2005). This suggests that these tumors arise from
Schwanncells or their progenitors. Nonetheless, important ques-
tions remain regarding the stage of Schwann cell development
that is rendered tumorigenic byNf1 deficiency. Mature Schwann
cells fail to become hyperproliferative upon Nf1 deletion or Ras
activation (Kim et al., 1995). In contrast, conditional deletion of
Nf1 from fetal nerve progenitors using Krox20-Cre leads to plex-
iform neurofibromas in spinal nerve roots (Zhu et al., 2002).SIGNIFICANCE
Cancers are often proposed to arise from stem cells that have been transformed by mutations that inappropriately activate
self-renewal mechanisms. Neurofibromas and MPNSTs arise from neural crest-derived cells and sometimes arise congen-
itally, raising the question of whether they arise from NCSCs. We found that Nf1 transiently inhibits the expansion of NCSCs
during midgestation but that Nf1-deficient NCSCs appear to acquire normal differentiated fates, do not become tumori-
genic, and do not persist postnatally. Instead, MPNSTs and plexiform neurofibromas appeared to arise from differentiated
glia that began proliferating inappropriately postnatally or during adulthood. Cancer and benign tumors in the PNS can,
therefore, arise from differentiated glia.
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Neurofibromas Arise from Differentiated GliaKrox20 is expressed by nerveNCSCs (T. Iwashita andS.J.M., un-
published data) in addition to Schwann cells and their committed
progenitors (Topilko et al., 1994; Zhu et al., 2002). Fate mapping
of Krox20-Cre expressing cells demonstrates that these cells
undergo multilineage differentiation in DRGs (Maro et al., 2004;
Zhu et al., 2002). These observations raise the question of
whether neurofibromas and MPNSTs arise from NCSCs or from
differentiated Schwann cells.
The neural crest is a heterogeneous population of progenitors
that migrates from the dorsal neural tube in early to midgestation
and gives rise to the neurons and glia of the PNS. NCSCs are a
subset of neural crest cells and are defined by the ability of
individual cells to self-renew and to undergo multilineage differ-
entiation into neurons, glia, and myofibroblasts (Morrison et al.,
1999; Stemple and Anderson, 1992). Postmigratory NCSCs
have been found in all regions of the fetal PNS including periph-
eral nerves, sympathetic chain, DRGs, and gut (enteric nervous
system) (Bixby et al., 2002; Morrison et al., 1999). In peripheral
nerves, NCSCs give rise to myelinating and nonmyelinating
Schwann cells as well as endoneurial fibroblasts (Joseph et al.,
2004), cell types that are present in neurofibromas.
NCSCs persist throughout adult life in the gut (Kruger et al.,
2002). However, in other regions of the PNS, including those
that develop neurofibromas, NCSCs terminally differentiate by
late gestation and cannot be detected postnatally (Kruger et al.,
2002). Nonetheless, NCSCs could still be rendered tumorigenic
by Nf1 mutations as plexiform neurofibromas and MPNSTs can
arise from mutations that occur during fetal development.
Some tumors are even evident in patients at birth (Rubin and
Gutmann, 2005). Other tumors develop around puberty or during
adulthood. Thus, if NCSCs are rendered tumorigenic by Nf1
deficiency, then deletion of Nf1 from fetal NCSCs should lead
to a sustained expansion of these cells, and their postnatal per-
sistence, such that they can give rise to neonatal or adult tumors.
Many cancers appear to arise from mutations that transform
normal stem cells by inappropriately activating self-renewal
pathways (Pardal et al., 2003; Reya et al., 2001). Nf1 inhibits
the proliferation, survival, and glial differentiation of CNS stem
cells (Dasgupta and Gutmann, 2005) and the proliferation of
CNS glial progenitors (Zhu et al., 2005b). These effects of Nf1
on CNS stem cells and glial progenitors appear to explain the
astrocytomas that arise in neurofibromatosis patients (Zhu
et al., 2005a). Although PNS tumors are more common than
CNS tumors in neurofibromatosis, the origin of PNS tumors
remains unknown.
We found that Nf1-deficient NCSCs from fetal DRGs, sciatic
nerves, and sympathetic ganglia exhibited increased frequency,
proliferation, self-renewal, andgliogenesis. To testwhether these
effects were sustained, we examined mice in which Nf1 was
conditionally deleted from the PNS using Wnt1-Cre, P0a-Cre,
or 3.9Periostin-Cre. We did not detect the persistence ofNf1-de-
ficientNCSCs in the postnatal DRG, sciatic nerve, or sympathetic
ganglia and NCSCs in the postnatal gut were not affected byNf1
deficiency. YetP0a-Cre+Nf1fl/mice developed plexiform neuro-
fibromas from adult nerves (Zheng et al., 2008 [this issue of Can-
cer Cell]). NCSCs also did not persist postnatally in the DRGs,
sciatic nerves, trigeminal nerve, brachial plexus, or sympathetic
ganglia ofNf1/p53+/miceorNf1+/Ink4a/Arf/mice. Yet, these
mice developed MPNSTs as adults. NCSCs are, therefore, not
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rofibromas and MPNSTs appear to arise from differentiated glia.
RESULTS
Nf1 Regulates NCSC Frequency throughout
Much of the Developing PNS
GermlineNf1/embryos die fromacardiac defect by embryonic
day (E)14.5 (Brannan et al., 1994; Jacks et al., 1994). Therefore, to
test whether Nf1 regulates NCSC function, we cultured NCSCs
from various regions of the PNS from E13 Nf1/ embryos and
littermate controls. NCSC frequency was assessed as the
percentage of cells from each region of the PNS that could
form self-renewing neurospheres that underwent multilineage
differentiation (Iwashita et al., 2003; Molofsky et al., 2005) (see
Figure S1 available with this article online). The sympathetic
chain, DRG, and sciatic nerve from Nf1/ embryos contained
a significantly higher percentage of cells (3- to 6-fold higher;
p < 0.05) that formed multipotent neurospheres in culture com-
pared to littermate controls (Figures 1A–1C). In contrast, Nf1-
deficiency did not increase the frequency of gut cells that formed
multipotent neurospheres. This suggests that Nf1 negatively
regulates the frequency of NCSCs from many, but not all, PNS
regions.
To test whether the increased frequency of Nf1/ NCSC col-
onies was attributable to an increased frequency of NCSCs
in vivo or increased survival by NCSCs in culture, we assayed the
frequency of p75+a4
+ cells among unculturedDRG, sciatic nerve,
sympathetic chain, and gut cells by flow-cytometry. p75+a4
+
cells from the fetal PNS are enriched for NCSCs (Iwashita et al.,
2003; Molofsky et al., 2005). Freshly dissociated Nf1/ DRG,
sciatic nerve, and sympathetic chain all had significantly (p <
0.05) higher frequencies of p75+a4
+ cells (Figures 1A–1C). In con-
trast, we did not observe a significantly higher frequency of
p75+a4
+ cells in the gut of Nf1/ mice (Figure 1D). These data
suggest that NCSC frequency is increased in vivo at E13 by
Nf1 deficiency.
Nf1 Regionally Regulates NCSC Proliferation
and Self-Renewal in the Developing PNS
In PNS regions whereNf1 negatively regulated NCSC frequency,
Nf1 also negatively regulated proliferation from NCSCs in cul-
ture. Multipotent neurospheres formed by NCSCs from DRG,
sciatic nerve, and sympathetic chain were significantly larger in
the absence of Nf1 (Figures 1A–1C). All cultures were initiated
with very low densities of cells (1000 to 5000 cells per 35 mm
dish forming up to 30 neurospheres per dish) so as to minimize
fusion between neurospheres. To ensure that the increased
size of colonies reflected increased proliferation by Nf1/
NCSCs, we also cultured these cells adherently. Adherent multi-
lineage colonies cultured at clonal density fromDRGand sympa-
thetic chain were also significantly larger in the absence of Nf1
(Figure S2). Increased proliferation contributed to the increased
size of NCSC colonies in the absence of Nf1 as we detected
a significantly increased rate of BrdU incorporation into Nf1/
colonies but no decrease in the frequency of cells undergoing
cell death (Figure S2I). In contrast, adherent NCSC colonies
cultured from the gut were not significantly larger nor did they
exhibit an increased rate of BrdU incorporation (Figure S2I).
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reflected increased self-renewal, we dissociated primary neuro-
spheres and subcloned them into secondary cultures to deter-
mine the number of multipotent daughter neurospheres that
arose per primary neurosphere. Secondary neurospheres were
always differentiated to assess multipotency (Figure S1). When
cultured from the DRG, nerve, or sympathetic chain, Nf1/
neurospheres gave rise to 4 to 10 times as many multipotent
daughter neurospheres as compared to control neurospheres
(Figures 1A–1C). In contrast, we detected no increase in self-re-
newal by Nf1/ gut neurospheres (Figure 1D). Nf1 negatively
Figure 1. Nf1Negatively Regulates the Frequency, Proliferation, and
Self Renewal of NCSCs in Most Regions of the Fetal PNS
DRG (A), sciatic nerve (B), sympathetic chain (C), and gut (D) were dissected
from E13 Nf1+/+, Nf1+/, and Nf1/ mouse embryos. Dissociated cells were
plated into nonadherent cultures at low density (1000 to 2500 cells/35 m well
for most tissues; 5000 for DRG). Neurospheres were cultured non-adherently
for 10 days, followed by 4 days in adherent cultures before being stained for
neurons, glia, and myofibroblasts. Typical neurospheres are shown along
with the percentage of freshly dissociated cells that formed neurospheres
that underwent multilineage differentiation (nsph freq), the diameter of these
neurospheres, and the number of multipotent secondary neurospheres
generated per primary neurosphere upon subcloning (self-renewal) (*p <
0.05 versus wild-type; #p < 0.05 versus heterozygous). The scale bar
(100 mm) in (A) applies to all panels. The frequency of p75+a4
+ cells among
freshly dissociated cells was significantly increased in DRG (A), sciatic nerve
(B), and sympathetic chain (C), but not gut (D). Culture data represent 8 to 12
experiments and flow-cytometry data represent 4 to 7 experiments per tissue.
All statistics are mean ± SD.regulates NCSC self-renewal in most regions of the develop-
ing PNS.
Increased Ras Signaling, Gliogenesis, and Growth
Factor Sensitivity by Nf1-Deficient NCSCs
Nf1/ cells exhibit increased sensitivity to growth factors that
signal through the Ras pathway (Vogel et al., 1995). To test
whether this was the case in NCSCs, we cultured NCSCs from
the gut, sciatic nerve, DRG, and sympathetic chain of E13
Nf1/ and littermate control embryos. Western blot demon-
strated increased phosphorylated Erk (pErk) in the Nf1/ colo-
nies, consistent with increased Ras signaling in these cells (Fig-
ure 2A). Gut neural crest cells also exhibited increased pErk in
the absence of Nf1 (Figure 2A) despite the fact that these cells
did not exhibit increased proliferation. The increased Ras signal-
ing by Nf1/ NCSCs suggests that these cells may exhibit
increased responses to growth factors that signal through Ras,
including factors that regulate survival, like FGF2, and gliogene-
sis, like Neuregulin (Nrg1). Indeed, addition of a short pulse of
Nrg1 to NCSC cultures increased pErk levels in wild-type cells
and further increased the elevated levels observed inNf1/ cells
(Figure 2B).
To test whether Nf1-deficiency affected the differentiation of
NCSCs, we cultured neurospheres from E13 Nf1/ and control
littermate embryos, then replated them in adherent cultures and
stained the colonies for neurons, glia, and myofibroblasts. Multi-
potent Nf1/ colonies exhibited much more exuberant gliogen-
esis (Figures 2E and 2H) as compared to control colonies (Fig-
ures 2C, 2D, 2F, and 2G). These colonies exhibited a dramatic
increase in the absolute numbers of glia per colony without ex-
hibiting decreases in the numbers of neurons or myofibroblasts
per colony (data not shown). Similar results were obtained with
nerve NCSCs, but we did not generally observe increased glio-
genesis by cultured gut NCSCs (data not shown). This indicates
that Nf1 negatively regulates gliogenesis from NCSCs, though
we do not know whether this reflects effects on glial lineage
determination, proliferation, or survival.
Nf1/ NCSCs also survived under adverse culture conditions
in which FGF2 and chick embryo extract concentrations were
reduced to levels that were non-permissive for the survival of
wild-type NCSCs. Nf1+/+ and Nf1+/ sympathetic chain or DRG
progenitors formed only rare colonies that contained small
numbers of myofibroblasts in this medium, while Nf1/ cells
formed multilineage colonies (Figure 2), albeit at a reduced fre-
quency as compared to standard medium (Figures 2L and 2M;
*p < 0.05).
Nf1-Deficient NCSCs Do Not Persist
Postnatally outside of the Gut
To test whetherNf1 deficiency leads to an ongoing postnatal ex-
pansion of NCSCs, we conditionally deleted Nf1 from neural
crest cells by crossing Wnt1-Cre mice (Danielian et al., 1998)
with Nf1fl mice (Zhu et al., 2001). Wnt1-Cre+Nf1fl/ mice die
at birth (Gitler et al., 2003), so cells were cultured from E17
to E19 embryos. We were never able to culture multilineage
NCSC colonies from the sciatic nerve or DRG of Wnt1-
Cre+Nf1fl/ embryos or controls (Table 1). We were able to cul-
ture rare NCSC colonies from the sympathetic chain and gut of
Wnt1-Cre+Nf1fl/ embryos and littermate controls, though their
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Neurofibromas Arise from Differentiated GliaFigure 2. Nf1-Deficient NCSCs Exhibit Increased Ras Signaling, In-
creased Gliogenesis, and Increased Survival in Low Growth Factor
Cultures
(A) Cell lysates from Nf1+/+ and Nf1/ neurospheres were analyzed for NF1
and phosphorylated Erk 42/44 (pErk) protein levels. (B) When Nf1+/+ and
Nf1/ NCSC cultures from sympathetic chain were pulsed with Nrg-1, pErk
levels increased in both Nf1+/+ and Nf1/ cells, but were highest in Nf1/
cells. NCSCs cultured from E13 Nf1+/+, Nf1+/, and Nf1/ DRGs (C–E) and
sympathetic chain (F–H) underwent multilineage differentiation, forming pe-
ripherin+ neurons, GFAP+ glia, and SMA+ myofibroblasts. More gliogenesis
(red) was observed from Nf1/ NCSCs from DRG (E) and sympathetic chain
(H). Nf1+/+ and Nf1+/ cells from sympathetic chain (I–J and L) and DRG (M)
failed to form multilineage colonies in low growth factor cultures (LGF), while
Nf1/ cells continued to do so ([K]; SMA+ myofibroblasts were present in
132 Cancer Cell 13, 129–140, February 2008 ª2008 Elsevier Inc.frequency was similar in Nf1+/+ and Nf1/ embryos (Table 1).
The expansion of Nf1/ NCSCs at E13 does not lead to the
inappropriate expansion or persistence ofNf1/NCSCs at later
stages of development.
To test whenNf1/NCSCs are lost from the developing PNS,
weanalyzedWnt1-Cre+Nf1fl/ embryos and littermate controls at
E13, E15, and E17–19. Like germline Nf1-deficient mice (Fig-
ure 1), we observed increased NCSC frequencies in E13 Wnt1-
Cre+Nf1fl/ embryos as compared to littermate controls in the
sympathetic chain, sciatic nerve, and DRG, but not in the gut
(Figures S3A–S3D). Nonetheless, the frequency of Nf1-deficient
NCSCs declined in all regions of the PNS by E15 and declined
further by E17. By E17–19, Nf1-deficient multipotent neuro-
spheres could only be detected in the sympathetic chain and
gut and did not differ in frequency as compared to littermate con-
trols. We confirmed that Nf1was efficiently deleted from NCSCs
in these experiments by genotyping individual neurospheres
cultured from the sympathetic chain, sciatic nerve, DRG, and
gut of E13Wnt1-Cre+Nf1fl/ embryos: all of the 25 neurospheres
exhibited deletion of theNf1fl allele (Figure S3H). These data sug-
gest that Nf1-deficient NCSCs differentiate during late gestation
according to a similar time course as wild-type NCSCs.
To independently test whether Nf1 deficiency leads to the
postnatal persistence of NCSCs, we generated 3.9Periostin-
Cre+Nf1fl/mice. 3.9Periostin-Cre conditionally deletes through-
out the Schwann cell lineage after E11, at a later stage of devel-
opment thanWnt1-Cre (Lindsley et al., 2007). We also observed
an increase in the frequency of NCSCs within the sympathetic
chain and sciatic nerve, but not the gut, of E15 3.9Periostin-
Cre+Nf1fl/ mice as compared to littermate controls (Figures
this colony outside of the field of view) ([L and M]; *p < 0.05 versus control cul-
tures). Brightfield (peripherin) and fluorescence (GFAP, SMA) images always
represent the same field of view within a single colony. The scale bar (100
mm) in (C) applies to all panels. Data represent 3–5 independent experiments
and error bars represent SD.
Table 1. Nf1 Deficiency Does Not Lead to the Persistence of
Expanded Numbers of NCSCs into Late Gestation or Postnatally
E17 to E19 Cells that Formed Multipotent Neurospheres
Littermate Controls Wnt1-Cre+Nf1fl/
DRG 0 ± 0% 0 ± 0%
Sciatic nerve 0 ± 0% 0 ± 0%
Sympathetic chain 0.03 ± 0.03% 0.05 ± 0.04%
Gut 0.08 ± 0.10% 0.08 ± 0.10%
P30 to P60 Cells that Formed Multipotent Neurospheres
Littermate Controls 3.9Periostin-Cre+Nflfl/
DRG 0 ± 0% 0 ± 0%
Sciatic nerve 0 ± 0% 0 ± 0%
Sympathetic chain 0 ± 0% 0 ± 0%
Gut 0.8 ± 0.6% 1.1 ± 0.8%
Tissueswere dissected, dissociated, and added to nonadherent cultures.
Neurospheres were replated to test multilineage differentiation into neu-
rons, glia, andmyofibroblasts. Wewere unable to detect NCSCs from the
DRGs, sciatic nerves, or sympathetic chain of young adult (P30 to P60)
3.9Periostin-Cre+Nflfl/ mice or littermate controls. All data represent
mean ± SD for 3 to 5 independent experiments per PNS region.
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Neurofibromas Arise from Differentiated GliaFigure 3. Adult P0aCre+Nf1fl/ Mice Devel-
oped Plexiform Neurofibromas but NCSCs
Appeared to Differentiate Normally and Did
Not Persist Postnatally
P0aCre+ Nf1-deficient mice developed plexiform
neurofibromas in adult peripheral nerves (B) and
DRGs (D), marked by increased cellularity and dis-
organization relative to control nerves (A) and
DRGs (C). Neurofibromas also exhibited increased
p75 (F) staining relative to control nerves (E). Multi-
potent neurospheres arose from control and
P0aCre+ Nf1-deficient gut, but not from other re-
gions of the adult PNS (G). Neural crest progeni-
tors in developing nerves were fate-mapped by
staining sciatic nerves from postnatal day 20
P0aCre+Nf1fl/+R26R (H and I), P0aCre+Nf1fl/
R26R (J and K), and P0aCre-Nf1fl/-R26R (L and
M) pups with bluo-gal (Joseph et al., 2004). We
detected no defects in nerve development in Nf1
mutant mice. A similar percentage of endoneurial
fibroblasts (green arrows) as well as myelinating
(red arrows) and nonmyelinating (blue arrows)
Schwann cells were bluo-gal+ in P0aCre+Nf1fl/
R26R nerves as compared to littermate controls
(N). No bluo-gal staining was observed in
P0aCreNf1fl/R26R negative control nerves (L
and M). The scale bar (100 mm) in (A) applies
to panels (A)–(F). Scale bars in (H)–(M) equal
2.5 mm. (n = 3–6 mice/genotype for [A]–[G] and
2 mice/genotype for [H]–[N]). All statistics are
mean ± SD.S3E–S3G). Genotyping of individual neurospheres showed
that Nf1 was efficiently deleted from these cells: 30 out of 30
neurospheres exhibited deletion of the Nf1fl allele (data not
shown).
Most 3.9Periostin-Cre+Nf1fl/ mice died by 4 weeks after
birth. Of 32 expected 3.9Periostin-Cre+Nf1fl/ mice, only 6 sur-
vived more than 4 weeks after birth. In these surviving mice,
NCSCs did not persist into adulthood in sciatic nerve, DRG, or
sympathetic chain in either 3.9Periostin-Cre+Nf1fl/ mice or lit-
termate controls (Table 1). As expected, NCSCs did persist
postnatally in the guts of 3.9Periostin-Cre+Nf1fl/mice and litter-
mate controls, but there was no difference in the frequency of
gut NCSCs in these mice (Table 1). Genotyping of individual
neurospheres cultured from the guts of adult 3.9Periostin-
Cre+Nf1fl/ mice showed that Nf1 was efficiently deleted from
these cells: 35 out of 35 neurospheres exhibited deletion of
the Nf1fl allele (data not shown). The expansion of NCSCs that
was observed at E13 in germline and conditional Nf1/
embryos was therefore only transient: Nf1/ NCSCs did not
persist postnatally in regions of the PNS where plexiform neuro-
fibromas form.
NCSCs Do Not Persist Postnatally in Mice
that Develop Plexiform Neurofibromas
We never detected PNS tumors in the limited number of
3.9Periostin-Cre+Nf1fl/ mice that survived into adulthood (twomice were analyzed at 3 weeks of age and six from 4 to 8 weeks
of age). To study mice that consistently survived into adulthood
after Nf1 deletion, we conditionally deleted Nf1 using P0a-Cre,
which deletes in trunk neural crest by E11.5 and in peripheral
nerves by E12.5 (Giovannini et al., 2000). P0 is expressed by
early migrating and multipotent neural crest cells (Hagedorn
et al., 1999; Lee et al., 1997). We sacrificed six P0a-Cre+ Nf1-
deficient mice and six littermate controls between 15 and 20
months of age and analyzed sciatic nerves, DRGs, trigeminal
nerves, and brachial plexi for plexiform neurofibromas. All six
of the P0a-Cre+ Nf1-deficient mice, but none of the littermate
controls, exhibited neurofibromas (Figures 3A–3F). Clas-
sic features of plexiform neurofibromas were evident in each
case, including grossly enlarged peripheral nerves and DRGs,
with increased cell density, nerve disorganization, and expres-
sion of p75 and S100 within the tumors (Figures 3B, 3D, and
3F).
To assess whether NCSCs persist into adulthood in these
mice, we dissociated and plated DRG, sciatic nerve, trigeminal
nerve, brachial plexus, sympathetic chain, and gut cells from
the P0a-Cre+ Nf1-deficient mice and littermate controls into
culture as described above. In each case, we sorted both unfrac-
tionated cells as well as p75+ cells into culture. p75+ cells from
the gut of P0a-Cre+ Nf1-deficient mice and littermate controls
formed multipotent neurospheres in culture (Figure 3G). How-
ever, no neurospheres formed in culture from any other region
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Neurofibromas Arise from Differentiated GliaFigure 4. ProliferatingCellswithinPlexiform
Neurofibromas Were p75+ and Expressed
Markers of Nonmyelinating Schwann Cells
Sciatic nerves (A, C–E, and F–K) and DRGs (B–E)
were dissected from adult P0aCre+ Nf1-deficient
mice with plexiform neurofibromas and littermate
controls. Mice were administered BrdU for 4 days
prior to being sacrificed. By flow-cytometry, neu-
rofibromas contained significantly higher frequen-
cies of p75+ cells (A–C), BrdU+ cells (A, B, and D),
and p75+BrdU+ cells (A, B, and E). The vast ma-
jority of dividing cells within neurofibromas were
p75+ (upper right quadrant of plots in [A] and [B]).
Immunofluorescence in sections confirmed the
increased frequency of BrdU+ cells ([F]; arrows),
p75+ cells (G), and GFAP+ cells (H) in neurofi-
bromas (right column) as compared to control
nerves (left column). Normal nerves and neuro-
fibromas lacked BFABP staining (I). Most BrdU+
cells costained with p75 (J), and many costained
with GFAP (K), markers of nonmyelinating
Schwann cells. In (J) and (K), double-positive cells
are indicated with arrows, while possible double-
positive cells are indicatedwith asterisks, and cells
that are only BrdU positive are indicated with
arrowheads. Scale bars in (F)–(K) equal 50 mm.
Error bars represent SD.
P0a-Cre+Nf1fl/R26R+mice as compared
to littermate controls. Bluo-gal+ endo-
neurial fibroblasts as well as myelinating
and nonmyelinating Schwann cells arose
with similar frequencies from P0a-
Cre+Nf1fl/R26R mice as compared to
P0a-Cre+Nf1fl/+R26R controls (Figures
3H–3N). These data suggest that Nf1-de-
ficient neural crest progenitors acquired
appropriate fates in developing periph-
eral nerves. Consistent with this, the
only abnormality in P0a-Cre+Nf1fl/ nerve
development detected in a companion
paper was the presence of rare nonmyeli-
nating Schwann cells that were associ-
ated with abnormal numbers of axonsof the PNS. These results demonstrate that we were able to
culture adult NCSCs from the guts of thesemice, but that NCSCs
did not persist postnatally in regions of the PNS affected by
neurofibromas.
NCSCs Appear to Differentiate Normally in the
Nerves of Mice that Develop Neurofibromas
We fate-mapped neural crest progenitors in developing nerves
by generating P0a-Cre+Nf1fl/R26R+ mice and littermate con-
trols. In these mice, the fate of P0a-Cre expressing progenitors
can be followed based on LacZ expression (R26R). Sciatic
nerves were dissected from postnatal day 20mice of each geno-
type, stainedwith bluo-gal, and analyzed by electronmicroscopy
(Joseph et al., 2004). We detected no gross abnormalities in the
size, composition, or histology of these postnatal nerves from
134 Cancer Cell 13, 129–140, February 2008 ª2008 Elsevier Inc.(Zheng et al., 2008). These data suggest
that Nf1-deficiency did not grossly alter nerve development or
the differentiated fates of neural crest progenitors.
Nonmyelinating Schwann Cells Proliferate
within Plexiform Neurofibromas
To address what cells were proliferating within the neurofi-
bromas that arose after Nf1 deletion with P0a-Cre, we analyzed
the neurofibromas by flow-cytometry and immunohistochemis-
try. We observed a significant increase (4.0- to 6.4-fold; p <
0.01) in the frequency of p75+ cells within the plexiform neurofi-
bromas in sciatic nerves and DRGs as compared to normal
nerves and DRGs from littermate controls (Figures 4A–4C). By
administering BrdU to mice for 4 days before analysis, we also
found that these p75+ cells were much more likely to be dividing
in neurofibromas as compared to normal tissue from littermate
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rates withNf1Mutations to Generate MPNSTs without the Postnatal
Persistence of NCSCs
(A) Nf1+/+ and Nf1/ neural crest cells cultured from sciatic nerve (SN) and
sympathetic chain (SC) were analyzed by western blot. (B) Ink4a deficiency
did not significantly affect the survival of Nf1+/ mice. (C) We detected no
MPNSTs among Nf1+/Ink4a/ mice or littermate controls. (D) The lifespan
of Nf1+/ mice was significantly (p < 0.05) decreased by Ink4a/Arf deficiency
as compared to littermate controls (* versus Nf1+/+Ink4aArf+/; # versus
Nf1+/Ink4aArf+/; d versus Nf1+/+Ink4aArf/). Each line in (B) and (D) repre-
sents a cohort of 34–61 mice per genotype (see numbers in [C] and [E]).
Nf1+/Ink4a/Arf / mice developed MPNSTs (E–J) as early as P30 but more
commonly after 4–6 months of age. Tumors were typically large ([F], arrow).
Paraffin sections exhibited classic features of MPNSTs including fascicular
patterns of tightly packed spindle cells ([G], arrows) with hyperchromatic nucleicontrols (Figures 4A, 4B, 4D, and 4E). Indeed, virtually all of the
dividing cells (BrdU+ cells) within neurofibromas were p75+
(Figures 4A and 4B). Since we could not culture NCSCs from
the nerves or DRGs of these adult mice, these data suggest
that nonmyelinating Schwann cells were proliferating within neu-
rofibromas, as nonmyelinating Schwann cells also express p75
(Jessen et al., 1990).
To test whether the proliferating p75+ cells within plexiform
neurofibromas expressed other markers of nonmyelinating
Schwann cells, we stained tumor sections with antibodies
against BrdU, p75, GFAP, and BFABP. We observed increased
numbers of BrdU+ cells (Figure 4F), p75+ cells (Figure 4G), and
p75+BrdU+ cells (Figure 4J) in neurofibromas as compared to
normal nerves, just as we had observed by flow cytometry (Fig-
ures 4A–4E). We also observed greatly increased numbers of
GFAP+ cells in neurofibromas (Figure 4H) and at least some of
these GFAP+ cells also appeared to be BrdU+ (Figure 4K),
though this was difficult to assess because GFAP is expressed
mainly in cell processes while BrdU is nuclear. Since GFAP is
expressed by nonmyelinating Schwann cells, but not by primitive
glial progenitors in E13 fetal nerves (which include NCSCs and
restricted Schwann cell precursors) (Jessen and Mirsky, 2005;
Jessen et al., 1990; Morrison et al., 1999), these data suggest
that GFAP+ nonmyelinating Schwann cells contribute to the
growth of neurofibromas. Neither normal nerves nor neurofi-
bromas exhibited detectable BFABP (also known as BLBP or
Fabp7) staining (Figure 4I). Primitive glial progenitors in embry-
onic nerves express BFABP, but adult nonmyelinating Schwann
cells do not (Britsch et al., 2001; Jessen and Mirsky, 2005). The
presence of large numbers of p75+, GFAP+, and BFABP cells
in neurofibromas, at least some of which are dividing, suggests
that nonmyelinating Schwann cells contribute to the growth of
neurofibromas.
Nf1 and p53 Mutations Lead to MPNSTs but
Not to the Postnatal Persistence of NCSCs
Nf1/p53+/ mice formed MPNSTs by 6 months of age (Figures
S4A–S4C) as previously reported (Cichowski et al., 1999; Vogel
et al., 1999). To test whether these mice maintained postnatal
NCSCs, we cultured dissociated cells from DRG, sciatic nerve,
trigeminal nerve, sympathetic chain, and gut of adult Nf1/p53+/
mice. Gut cells from Nf1/p53+/ mice and littermate controls
formed NCSC colonies in culture, but Nf1/p53 heterozygosity
did not affect the frequency or growth of these cells (Figure S4D).
We did not detect cells from the DRG, sciatic nerve, trigeminal
nerve, or sympathetic chain ofNf1/p53+/mice or littermate con-
trols that could form NCSC colonies (Figure S4D). Nf1 and p53
mutations did not affect the ability of fetal or adult NCSCs to
form colonies in culture or to undergo multilineage differentiation
(Figure S5A andS5E), so thesemutations did not prevent us from
and frequent mitoses (G). These tumors contained S100+ cells (H), a marker
used in the diagnosis of MPNSTs. Some tumors were found embedded in
the dermis (I and J) surrounding fat cells ([I], blue arrows), sebaceous glands
([I], arrows), and hair follicles ([I], arrowheads). Dermal tumors stained more in-
tensely for S100 (J) thanMPNSTs outside of the dermis (H). Scale bars in (G)–(J)
equal 100 mm. (K) Multipotent neurospheres consistently arose from Nf1+/
Ink4a/Arf / and control guts, but not from other regions of the adult PNS
(*these tissues were analyzed relative to age-matched wild-type controls).
Statistics represent mean ± SD for 3–6 independent experiments.
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the formation of MPNSTs during adulthood without promoting
the postnatal persistence of NCSCs, suggesting that MPNSTs
do not arise from NCSCs.
We also examined DRGs, sciatic nerves, trigeminal nerves, bra-
chial plexi, and sympathetic ganglia from 3- to 6-month-old Nf1/
p53+/ mice prior to the formation of MPNSTs to assess whether
therewereanyabnormalities inPNSdevelopment.Except forasin-
gleNf1/p53+/brachialplexus thatexhibitedhyperproliferation,we
were unable to distinguish Nf1/p53+/ tissues from wild-type tis-
sues by histology or marker expression (Figure S6). We also did
not detect any increase in the frequency of p75+ cells in adult
Nf1/p53+/ tissues prior to the development of MPNSTs (Figure
S6S). The failure to detect significantly increased numbers of
p75+ cells in adult Nf1/p53+/ tissues prior to the development of
tumors supports the conclusion that these tumors do not arise
fromthepostnatalpersistenceofexpandedpopulationsofNCSCs.
Ink4a and Arf Deficiency Cooperate with Nf1
Heterozygosity to Yield MPNSTs
To test whether the postnatal persistence of NCSCs might be
inhibited by induction of p16Ink4a or p19Arf expression in Nf1mu-
tant NCSCs we performed western blots on cultured NCSCs
from the sciatic nerve and sympathetic chain. In both cases,
we observed increased p19Arf expression by Nf1/ cells (Fig-
ure 5A). We also observed an increase in p16Ink4a expression
by Nf1/ sciatic nerve cells, though the effect on p16Ink4a
expression in sympathetic chain cells was not as clear. Consis-
tent with the known role for p53 mutations in the formation of
MPNSTs, we also observed a consistent increase in p21Cip1
expression by Nf1/ NCSCs (Figure 5A). These observations
raised the possibility that increased p16Ink4a and p19Arf expres-
sion by Nf1/ NCSCs might retard the formation of MPNSTs.
To test this, we first generated mice bearing mutations in Nf1
and Ink4a (leaving Arf intact). We aged cohorts ofNf1+/Ink4a/
mice as well as various genotypes of littermate controls for up
to 16 months. Overall mortality was low (Figure 5B). We never
detected any MPNSTs or neurofibromas in these mice, though
we did observe some hematopoietic neoplasms, particularly
lymphoma (Figure 5C). The lack of grossly evident PNS tumors
in these mice suggested that Ink4a deletion is not sufficient for
tumorigenesis in an Nf1 heterozygous background. Nf1+/ mice
were previously generated on an Arf-deficient background and
also did not develop neurofibromas or MPNSTs (King et al.,
2002). These observations are consistent with genetic analyses
of MPNSTs in patients, which usually exhibit loss-of-function
mutations in both the Rb and p53 pathways (Agesen et al.,
2005; Perrone et al., 2003).
To develop a mouse model that more faithfully recapitulated
the mutations observed in human MPNSTs, we generated mice
bearing mutations in Nf1 and Ink4a/Arf (lacking both Ink4a and
Arf). We aged cohorts of Nf1+/Ink4a/Arf/mice as well as var-
iousgenotypes of littermate controls for up to 16months. Virtually
all Nf1+/Ink4a/Arf/ mice died by 10 months of age, more
quickly than littermates with other genotypes (Figure 5D). Nf1+/+
Ink4a/Arf+/ control mice failed to develop MPNSTs or neurofi-
bromas, but 26% of Nf1+/Ink4a/Arf/ mice had to be eutha-
nized due to the formation of MPNSTs (Figures 5E and 5F).
Most of the MPNSTs developed by Nf1+/Ink4a/Arf/ mice
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tended to develop on the shoulders, ribs, or legs of mice, close
to DRGs and peripheral nerves. Much lower rates of MPNSTs
were observed among Nf1+/Ink4a/Arf+/ mice (Figure 5E), and
only after 1 year of age. These statistics may underestimate the
true frequency of MPNSTs, as smaller tumors may have gone
undetected in mice that died due to other causes.
Histology of the MPNSTs revealed typical features including
fascicular patterns of tightly packed spindle cells with hyperchro-
matic nuclei and frequent mitoses (Figure 5G) as well as S100
staining (Figure 5H). Five of the MPNSTs observed in Nf1+/
Ink4a/Arf/ mice were confined to the dermis and epidermis
(Figure 5I), were much smaller than the more typical tumors im-
aged inFigure 5F, andstainedmore intensely forS100 (Figure5J).
These tumors may actually be dermal neurofibromas, though
they were characterized as MPNSTs because the frequent
mitotic figures and invasivenessweremore consistent with ama-
lignancy. These data demonstrate that Ink4a/Arf deficiency leads
to the formation of MPNSTs in an Nf1+/ background.
In addition to forming MPNSTs, we observed a significant
frequency of hematopoietic neoplasms among Nf1+/Ink4a/
Arf/, Nf1+/Ink4a/Arf+/, and Nf1+/+Ink4a/Arf/ mice (Fig-
ure 5E). These included mainly lymphomas and histiocytic neo-
plasms, but we observed some acute myeloid leukemias as
well as some mice with myeloproliferative disease.
NCSCs Did Not Persist Postnatally
in Nf1+/Ink4a/Arf/ Mice
To test whether Nf1+/Ink4a/Arf/ mice maintained postnatal
NCSCs, we cultured dissociated cells from DRG, sciatic nerve,
trigeminal nerve, brachial plexus, sympathetic chain, and gut of
adult Nf1+/Ink4a/Arf/ mice and littermate controls. Gut cells
from Nf1+/Ink4a/Arf/ mice and controls formed multilineage
NCSC colonies in culture, but we did not detect a significantly
increased frequency of NCSCs in Nf1+/Ink4a/Arf/ mice
(Figure 5K). Nf1 deficiency also did not affect the size of gut
NCSC colonies (data not shown). We did not detect cells from
any other region of the PNS of Nf1+/Ink4a/Arf/ mice or litter-
mate controls that could form multipotent neurospheres
(Figure 5K). Nf1 and Ink4a/Arfmutations did not affect the ability
of fetal or adult NCSCs to form colonies in culture or to undergo
multilineage differentiation (Figures S5B and S5F), so these mu-
tations did not prevent us from detecting NCSCs in culture.
We also examined DRGs, sciatic nerves, trigeminal nerves,
and sympathetic ganglia from 3- to 6-month-old Nf1+/Ink4a/
Arf/mice prior to the formation of MPNSTs to assess PNS de-
velopment.Wewere unable to distinguishNf1+/Ink4a/Arf/ tis-
sues fromwild-type tissues by either histology or marker expres-
sion and did not detect a significant increase in the frequency of
p75+ cells in adult Nf1+/Ink4a/Arf/ tissues prior to the devel-
opment of MPNSTs (Figure S6). The failure to detect significantly
increased numbers of p75+ cells in adult Nf1+/Ink4a/Arf/ tis-
sues prior to the development of tumors supports the conclusion
that these tumors do not arise from the postnatal persistence of
expanded populations of NCSCs.
Clonogenic MPNST Cells Did Not Resemble NCSCs
To test whether clonogenic MPNST cells resembled NCSCs,
tumors from Nf1+/Ink4aArf/ mice or Nf1/p53+/ mice were
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Some Nf1+/Ink4a/Arf/ MPNST cells and Nf1/p53+/ MPNST
cells formed spheres in culture (Figures 6G and 6M). These
sphere-forming cells had self-renewal potential, giving rise to an
averageof 164± 133and104± 21daughter spheres, respectively,
when subcloned after 10 to 12 days of primary culture. These
sphere-forming cells were unlikely to arise from normal cells in
the tumors because we were unable to culture sphere-forming
Figure 6. Self-Renewing Spheres Grew fromNf1+/Ink4a/Arf / and
Nf1/p53+/ MPNSTs but Did Not Form Colonies that Resembled
NCSCs Colonies
Some MPNST cells from Nf1+/Ink4aArf/mice and Nf1/p53+/mice formed
self-renewing spheres in culture. While all NCSCs generated peripherin+ neu-
rons (B), GFAP+ glia (C), and SMA+ myofibroblasts ([C]; arrow), MPNST colo-
nies from Nf1+/Ink4aArf/ and Nf1/p53+/ mice failed to generate periph-
erin+ neurons (H and N) or GFAP+ glia (I and O). In contrast to Nf1/ NCSC
colonies (D), MPNST colonies exhibited little or no Sox10 staining (J and P).
MPNST colonies typically contained cells with a glial morphology (data not
shown) as well as SMA+ myofibroblasts (I and O). Like Nf1/ NCSC colonies
(E and F), most cells within MPNST colonies were SoxE+ (K and Q) and S100b+
(L and R). These represent typical colonies from six independent Nf1+/Ink4a/
Arf/ MPNSTs and four independent Nf1/p53+/ MPNSTs. The scale bar
(100 mm) in (A) applies to (A), (G), and (M) while the scale bar (100 mm) in (B)
applies to all other panels.cells from normal adult nerves in control mice (Figure 5K). All
Nf1/ (Figures 6A–6F) and wild-type (Figures 2C and 2F) NCSC
colonies formed peripherin+ neurons (Figure 6B), smooth muscle
actin+ (SMA+) myofibroblasts (Figure 6C), and GFAP+ glia (Fig-
ure 6C). Moreover, E13 Nf1/Ink4a/Arf/ and Nf1/p53/
NCSCs also underwent multilineage differentiation, as did adult
gut Nf1+/Ink4a/Arf/ and Nf1/p53+/ NCSCs (Figure S5). These
data demonstrate that Nf1 deficiency, with or without additional
mutations in p53 or Ink4a/Arf, does not alter the ability of NCSCs
to undergo multilineage differentiation. In contrast, the Nf1+/
Ink4a/Arf/ MPNST and Nf1/p53+/ MPNST colonies in the
same culture conditions rarely generated peripherin+ neurons
and never GFAP+ glia (Figure 6). Clonogenic MPNST cells fail to
undergo multilineage differentiation characteristic of NCSCs.
While cells within NCSC colonies were Sox10+ as expected
(Kim et al., 2003), MPNST cells stained weakly or not at all for
Sox10, as previously reported (Levy et al., 2004; Miller et al.,
2006) (Figure 6). Apart from the lack of GFAP staining, most cells
inMPNST colonies otherwise resembled glia, as theywere small,
spindle-shaped cells that stained positively for SoxE (Sox8/9/10)
and S100b (Figure 6). Increased Sox9 expression is typical of
MPNSTs, and a subset of MPNSTs express S100b (Miller
et al., 2006; Takeuchi and Uchigome, 2001). MPNST cells
thus formed colonies that consistently differed from wild-type
(Figures 2C and 2F), Nf1/ (Figures 6A–6F), Nf1/Ink4aArf/
(Figure S5B), and Nf1/p53/ (Figure S5A) NCSCs, though these
cells did resemble Schwann cells based on morphology and
expression of S100b and SoxE.
Nf1-Deficient NCSCs Are Not Tumorigenic
To test whether Nf1-deficient NCSCs could form tumors, we
cultured NCSCs from E13 Nf1+/+ or Nf1/mice or MPNST cells
from Nf1+/Ink4a/Arf/ mice, then transplanted these cells into
the sciatic nerves of adultNf1+/mice. In some experiments, the
Nf1 mutant allele was bred onto a Rosa background so that we
could monitor the engraftment of the transplanted cells. All mice
(8/8) injected with 50,000 MPNST cells developed large tumors
within 2 to 6 weeks of injection (Figures 7I and 7J). None of
12 mice injected with 50,000 to 100,000 Nf1+/+ cells or 16 mice
injected with 50,000 to 100,000 Nf1/ cells developed tumors
despite being monitored for up to 20 months after injection (Fig-
ure 7J). The Nf1+/+ and Nf1/ cells did engraft within nerves as
indicated by the presence of LacZ expressing cells (Figures 7E–
7H). However, these LacZ+ donor cells never formed tumors
(Figures 7G and 7H). Together, our data indicate that NCSCs
are not rendered tumorigenic by Nf1 deficiency, but rather infre-
quent differentiated glia (such as nonmyelinating Schwann cells)
begin proliferating inappropriately and form tumors in adults.
DISCUSSION
If NCSCs give rise to plexiform neurofibromas and MPNSTs,
then Nf1-deficient NCSCs would be expected to persist in
expanded numbers throughout late gestation and into the post-
natal period. However, we did not detect the postnatal persis-
tence of NCSCs in DRG, sympathetic chain, trigeminal ganglion,
brachial plexus, or peripheral nerve of conditional Nf1-deficient
mice (Table 1), even in mice that went on to develop plexiform
neurofibromas (Figure 3G). The expansion of Nf1-deficient
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type NCSCs, Nf1-deficient NCSCs became increasingly rare in
late gestation and failed to persist postnatally, precluding them
Figure 7. Nf1-Deficient NCSCs Are Not Tumorigenic In Vivo
We transplanted 50,000 MPNST cells or 50,000–100,000 Nf1+/+ or Nf1/
NCSCs into the nerves of adult Nf1+/ mice. NCSCs were grown as spheres
from various regions of the E13 PNS of Nf1+/+ and Nf1/ mice that had
been bred to Rosa mice in some experiments to allow the tracking of cells
with Xgal staining (A and B). NCSC sphereswere replated to adherent cultures,
dissociated to single cell suspensions, and injected into the sciatic nerves of
adult Nf1+/ mice. Contralateral nerves never showed X-gal+ cells (C and D)
but nerves injected with Rosa+ cells consistently showed engraftment (E–H).
MPNST spheres from Nf1+/Ink4aArf/ mice were also dissociated and in-
jected into the sciatic nerves of adult Nf1+/ mice (I). Tumors were never ob-
served in mice injected with Nf1+/+ or Nf1/ neural crest cells, even after 20
months follow-up (E–J). MPNST cells gave rise to large tumors (I) in all recipi-
ents within 2–6 weeks after injection (J). The scale bar (100 mm) in (A) applies to
(A) and (B) and the scale bar (100 mm) in (C) applies to (C)–(H).
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not persist postnatally in Nf1+/Ink4aArf/ or Nf1/p53+/ mice
(Figure 5K; Figure S4), despite the fact that they went on to de-
velop MPNSTs as adults (Figure 5; Figure S4). Since NCSCs
did not persist postnatally in regions of the PNS that formed plex-
iform neurofibromas or MPNSTs during adulthood, NCSCs
could not have given rise to these tumors.
Our inability to detect Nf1-deficient NCSCs postnatally in
regions of the PNS that developed tumors did not simply reflect
altered differentiation or survival of these cells in culture. In all
experiments, we were able to detect the postnatal persistence
of both wild-type and Nf1-deficient NCSCs from the adult gut.
This positive control demonstrated that we were able to culture
adult NCSCs from each of the genetic backgrounds we studied.
Moreover,Nf1 deficiency increased the survival and proliferation
of NCSCs in culture, making them easier, not more difficult, to
grow (Figure 2). Furthermore, Nf1 deficiency, with or without
p53 or Ink4a/Arf deficiency, did not alter the ability of NCSCs
to undergo multilineage differentiation (Figure 2; Figure 6; Fig-
ure S1; Figure S5).
Nf1-deficient NCSCs appeared to differentiate normally in pe-
ripheral nerves during late gestation (Figure 3). We did not detect
any gross alterations in nerve development in P20 Nf1 mutant
mice by electron microscopy (Figure 3). Rather, hyperplasia
and increased frequencies of p75+ cells were not observed in
P0a-Cre+Nf1fl/ mice until around 3 months of age (Zheng et al.,
2008). We also did not detect any gross alterations in PNS devel-
opment or a significant increase in the frequency of p75+ cells in
PNS tissues from Nf1+/Ink4aArf/ or Nf1/p53+/ mice during
early adulthood prior to the formation of tumors (Figure S6).
When combined with the observation that Nf1-deficient NCSCs
were lost from the late gestation PNS according to a similar time
course as wild-type NCSCs (Figure S3), and the observation
that Nf1-deficient NCSCs failed to form tumors after transplanta-
tion into adultNf1+/peripheral nerves (Figure7), our data suggest
that Nf1-deficient NCSCs terminally differentiate during late ges-
tation and are long gone by the time tumors arise in the adult PNS.
Our data instead suggest that infrequent differentiated glia,
such as nonmyelinating Schwann cells within peripheral nerves,
begin proliferating inappropriately in the postnatal period and
give rise to plexiform neurofibromas. The dividing cells within
plexiform neurofibromas were almost exclusively p75+ (Figures
4A, 4B, and 4J). Many of these cells had a phenotype similar to
nonmyelinating Schwann cells (and dissimilar to fetal NCSCs)
as they were also GFAP+ and BFABP (Figure 4). Proliferating
cells within MPNSTs also expressed some differentiated glial
markers as well as having a glial morphology (Figure 6).
Why would deletion ofNf1 in fetal nerve progenitors lead to the
formation of tumors that donot becomeevident until adulthood in
mice (Zhu et al., 2002)? A cosubmitted manuscript by Zheng and
colleagues concludes that abnormal differentiation of some
nonmyelinatingSchwann cells in the absence ofNf1 leads to their
association with unusually large numbers of axons (Zheng et al.,
2008). These bundles degenerate postnatally, leading to inflam-
mation that precedes Schwann cell hyperproliferation and the
formation of plexiform neurofibromas. These observations sug-
gest that Nf1-deficient Schwann cells differentiate perinatally
and do not become hyperproliferative until early adulthood
when their behavior is modified by epigenetic (i.e., inflammation,
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tions) triggers.
Our results do not address the origin of dermal neurofibromas.
Typical benign dermal neurofibromas did not arise in any of the
mice we studied. Neural progenitors have been cultured from
adult dermis and at least some of these are neural crest derived
(Fernandes et al., 2004; Wong et al., 2006). While these cells ex-
press markers similar to NCSCs, the progenitors cultured from
trunk skin have little capacity to make neurons (Wong et al.,
2006), in contrast to theNCSCpopulationswehavecharacterized
(Bixby et al., 2002;Kruger et al., 2002;Morrison et al., 1999).More
workwill be required to identify the in vivo cells that give rise to the
dermally derived neural progenitors. Nonetheless, this is a differ-
ent neural progenitor population, in a different location, than the
NCSC populations that we characterized in this study.
It is interesting that NF1 negatively regulates the frequency,
self-renewal, growth factor sensitivity, and gliogenesis of
NCSCs in most regions of the PNS but not in the gut. The basis
for this regional difference in NF1 function is not clear. Nonethe-
less, these results are consistent with the observation that
neurofibromatosis patients seem more likely to develop tumors
from peripheral nerves, DRGs, and sympathetic ganglia than
from the gut (Fuller and Williams, 1991). The failure of gut neural
crest progenitors to exhibit increased proliferation or gliogenesis
after Nf1 deletion may partly explain this clinical observation.
While many cancersmay arise from the transformation of stem
cells, our results indicate that NCSCs are not rendered tumori-
genic by mutations in Nf1. Benign tumors and cancers of the
PNS can arise from differentiated glia.
EXPERIMENTAL PROCEDURES
All experiments using mice were performed in accordance with approved pro-
tocols by the University Committee on the Use and Care of Research Animals
(UCUCA). SeveralNf1 alleles were used in these studies including Nf1 (germ-
line mutant) mice (Jacks et al., 1994), Nf1fl mice for conditional deletion (Zhu
et al., 2001), and Nf1/p53 cismutant mice (Cichowski et al., 1999). For condi-
tional deletion ofNf1we usedWnt-1-Cre+ (Danielian et al., 1998), 3.9Periostin-
Cre+ (Lindsley et al., 2007), and P0a-Cre+ (Giovannini et al., 2000) mice. Com-
pound mutant mice were generated by mating Nf1+/mice with Ink4a/mice
(Sharpless et al., 2001) or Ink4aArf/ mice (Serrano et al., 1996).
Isolation of NCSCs
Timed pregnant matings of Nf1+/mice were set up to obtain E13 Nf1/ em-
bryos. DRGs (cervical, thoracic, and lumbar), sciatic nerve, sympathetic chain,
and gut (including stomach, small intestine, and hindgut) were dissected from
E12.5 to E13.5 Nf1+/+, Nf1+/, and Nf1/ littermates and collected in ice-cold
Ca, Mg-free HBSS. Tissues were dissociated for 4 min at 37C in 0.05% tryp-
sin/EDTA (Invitrogen, Carlsbad, California; diluted 1:10 in Ca, Mg-free HBSS)
with 0.25 mg/ml type IV collagenase (Worthington, Lakewood NJ) then
quenched with staining medium: L15 medium containing 1 mg/ml BSA (Sigma
A-3912, St. Louis, MO), 10 mM HEPES (pH 7.4), 1% penicillin/streptomycin
(BioWhittaker, Walkersville, MD), and 25 mg/ml deoxyribonuclease type 1
(DNase1, Sigma D-4527). Cells were centrifuged, resuspended in staining
medium without DNase, triturated, filtered through nylon screen (45 mm, Sefar
America, Kansas City, MO) to remove aggregates, counted by hemocyto-
meter, and added to culture. In some experiments, cell suspensions were
stained with antibodies against p75 (Ab 1554; Chemicon) and a4 integrin
(Becton Dickinson, San Jose, CA) for analysis by flow-cytometry (Bixby
et al., 2002). In some experiments, cells were stained for BrdU using a flow-
cytometry kit (BD PharMingen; cat. no. 559619). Flow cytometry was per-
formed with a FACSVantage SE-dual laser, three-line flow-cytometer (Becton
Dickinson).See Supplementary Data for details regarding dissociation of adult cells,
genotyping, cell culture, immunohistochemistry, western blots, nerve injec-
tions, and other methods.
Supplemental Data
The Supplemental Data include six supplemental figures and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cancercell.org/cgi/content/full/13/2/129/DC1/.
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